Recommended International Nonproprietary Names

Nations Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, Withdrawn, Severely Restricted or not Approved by Governments. WHO publishes updates to this list Pharmaceuticals Restrictions in use and availability. WHO publishes also quarterly WHO Drug Information (http //www.who.int/druginformation/) journal which provides an overview of topics of current relevance relating to drug development, safety and regulation. Latest lists of proposed and recommended International Nonproprietary Names (INN) for Pharmaceutical Substances are also published in this journal. [Pg.75]

Spelling of drug names. The World Health Organization devises recommended International Nonproprietary Names (rINN). These are becoming universal most do not give rise to any confusion, but occasionally we insert an alternative name or spelling. [Pg.28]

A nonproprietary (official, approved, generic) name used in pharmacopoeias and chosen by official bodies the World Health Organization (WHO) chooses recommended International Nonproprietary Names (rINN). The harmonisation of names began 50 years ago, and... [Pg.83]

International travellers with chronic illnesses will be grateful for recommended International Nonproprietary Names (above) as proprietary names often differ from country to country. The reasons are linguistic as well as commercial (see below). [Pg.85]

Where no objection has been filed under article 5, or all objections previously filed have been withdrawn, the Secretariat shall give notice in accordance with subsection (a) of article 3 that the name has been selected by WHO as a recommended international nonproprietary name. [Pg.876]

In forwarding a recommended international nonproprietary name to Member States under article 7, the Secretariat shall ... [Pg.876]

A. hi the extraordinary circumstance that a previously recommended international nonproprietary name gives rise to errors in medication, prescription, or distribution, or a demonstrable risk thereof, because of similarity with another name in pharmaceutical and/or prescription practices, and it appears that such errors or potential errors cannot readily be resolved through other interventions than a possible substitution of a previously recommended international nonproprietary name, or in the event that a previously recommended international nonproprietary name differs substantially from the nonproprietary name approved in a significant number of Member States, or in other such extraordinary circumstances that justify a substitution of a recommended international nonproprietary name, proposals to that effect may be filed by any interested person. Such proposals shall be submitted on the form provided therefore and shall ... [Pg.876]

Several barbiturates of therapeutic importance have common names or names adopted by manufacturers but we will use only their recommended international nonproprietary names [e.g., methylphenobarbital (3)].6... [Pg.230]

Names, the National Institute of Occupational Safety and Health (NIOSH) Registry of Toxic Effects of Chemical Substances, and the proposed and recommended International Nonproprietary Names lists published by the World Health Organization. [Pg.128]

PROCEDURE FOR THE SELECTION OF RECOMMENDED INTERNATIONAL NONPROPRIETARY NAMES FOR... [Pg.699]

Proposals for recommended international nonproprietary names shall be submitted to the World Health Organization on the fomr provided therefore. [Pg.699]

Where there is a formal objection under article 5, the World Health Organization may either reconsider the proposed name or use its grxxl offices to attempt to obtain withdrawal of the objection. Without prejudice to the (xinsidetation by the World Health Organization of a substitute name or names, a name shaR not be selerdsd by the World Health Organizatfon as a recommended International nonproprietary name while there exists a formal objection thereto filed under article 5 which has not been withdrawn. [Pg.699]

Fig, 41,3 Procedure for the selection of recommended international nonproprietary names for pharmaceutical substances. [Pg.699]

Nomenclature—The recommended international nonproprietary name (INN), U.S.-adopted name (USAN) and other national names are included, if available, along with the full chemical name(s) and any internal code names or numbers for the API. Additionally, trade names for the intended formu-lation(s) and the CAS number for the API may be provided, if established. [Pg.182]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...